Betoptic

Active Ingredient(s): Betaxolol
FDA Approved: * August 30, 1985
Pharm Company: * ALCON
Category: Blood Pressure

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Betoptic Overview

Betaxolol (trade names Betoptic, Betoptic S, Lokren, Kerlone) is a selective beta1 receptor blocker used in the treatment of hypertension and glaucoma.[1] Being selective for beta1 receptors, it typically has fewer systemic side effects than non-selective beta-blockers, for example, not causing bronchospasm (mediated by beta2 receptors) as timolol may. Betaxolol also shows greater affininty for beta1 receptors than metoprolol. In addition to its effect on the heart, betaxolol reduces the pres...

Read more Betoptic Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Betaxolol

Recent Betoptic Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Betaxolol
  • Solution: 0.5%
  • Solution/drops: 0.5%
  • Suspension: 0.25%
  • Tablet: 10mg, 20mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Betaxolol or a similar ingredient: (4 results)


Possibly related Betoptic Topics:

Betoptics Eyedrops for Glaucoma...




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. Site content is Copyright © 2005-2017 MedsChat.com and is protected under U.S. and International Copyright laws. All Rights Reserved. This page was last updated on 19 September 2017.

We are committed to your privacy.

Copyright © 2005-2017 All Rights Reserved. MedsChat® and The People's Medicine Community® are registered trademarks of Limelight Innovations L.L.C.